APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadoterate Meglumine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gadoterate Meglumine Industry Growth and Trends Forecast to 2032

19 December 202576 pages

Choose your research edition.

Industry ResearchGadoterate Meglumine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadoterate Meglumine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Gadoterate Meglumine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadoterate Meglumine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadoterate Meglumine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gadoterate Meglumine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gadoterate Meglumine include Hengrui Medicine, Guerbet Group and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gadoterate Meglumine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gadoterate Meglumine market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gadoterate Meglumine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gadoterate Meglumine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gadoterate Meglumine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gadoterate Meglumine Market by Company

Hengrui Medicine

Guerbet Group

GE Healthcare

Gadoterate Meglumine Segment by Type

5.6535Gm/15Ml

3.769Gm/10Ml

1.8845Gm/5Ml

Others

Gadoterate Meglumine Segment by Application

Hospitals

Clinics

Gadoterate Meglumine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadoterate Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadoterate Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadoterate Meglumine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gadoterate Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5.6535Gm/15Ml Table 2. Major Company of 3.769Gm/10Ml Table 3. Major Company of 1.8845Gm/5Ml Table 4. Major Company of Others Table 5. Global Gadoterate Meglumine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 7. Global Gadoterate Meglumine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Gadoterate Meglumine Sales Market Share in Value by Type (2021-2026) Table 10. Global Gadoterate Meglumine Price by Type (2021-2026) & (US$/L) Table 11. Global Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 12. Global Gadoterate Meglumine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Gadoterate Meglumine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Gadoterate Meglumine Sales Market Share in Value by Type (2027-2032) Table 15. Global Gadoterate Meglumine Price by Type (2027-2032) & (US$/L) Table 16. North America Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 17. North America Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 19. Europe Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 21. Asia-Pacific Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 23. Latin America Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 25. Middle East and Africa Gadoterate Meglumine Sales by Type (2021-2026) & (US$ Million) Table 26. Gadoterate Meglumine Industry Trends Table 27. Gadoterate Meglumine Industry Drivers Table 28. Gadoterate Meglumine Industry Opportunities and Challenges Table 29. Gadoterate Meglumine Industry Restraints Table 30. Global Gadoterate Meglumine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Gadoterate Meglumine Revenue Market Share by Company (2021-2026) Table 32. Global Gadoterate Meglumine Sales by Company (2021-2026) & (K L) Table 33. Global Gadoterate Meglumine Sales Share by Company (2021-2026) Table 34. Global Gadoterate Meglumine Market Price by Company (2021-2026) & (US$/L) Table 35. Global Gadoterate Meglumine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Gadoterate Meglumine Major Company Production Sites and Headquarters Table 37. Global Gadoterate Meglumine Company, Product Type & Application Table 38. Global Gadoterate Meglumine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Gadoterate Meglumine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Gadoterate Meglumine Sales by Region (2021-2026) & (K L) Table 43. Global Gadoterate Meglumine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Gadoterate Meglumine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Gadoterate Meglumine Sales Market Share in Value by Region (2021-2026) Table 46. Global Gadoterate Meglumine Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 47. Global Gadoterate Meglumine Sales by Region (2027-2032) & (K L) Table 48. Global Gadoterate Meglumine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Gadoterate Meglumine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Gadoterate Meglumine Sales Market Share in Value by Region (2027-2032) Table 51. Global Gadoterate Meglumine Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 52. Global Gadoterate Meglumine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 54. Global Gadoterate Meglumine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Gadoterate Meglumine Sales Market Share in Value by Application (2021-2026) Table 57. Global Gadoterate Meglumine Price by Application (2021-2026) & (US$/L) Table 58. Global Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 59. Global Gadoterate Meglumine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Gadoterate Meglumine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Gadoterate Meglumine Sales Market Share in Value by Application (2027-2032) Table 62. Global Gadoterate Meglumine Price by Application (2027-2032) & (US$/L) Table 63. North America Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 64. North America Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 66. Europe Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 68. Asia-Pacific Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 70. Latin America Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 72. Middle East and Africa Gadoterate Meglumine Sales by Application (2021-2026) & (US$ Million) Table 73. Hengrui Medicine Company Information Table 74. Hengrui Medicine Business Overview Table 75. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 76. Hengrui Medicine Gadoterate Meglumine Product Portfolio Table 77. Hengrui Medicine Recent Development Table 78. Guerbet Group Company Information Table 79. Guerbet Group Business Overview Table 80. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 81. Guerbet Group Gadoterate Meglumine Product Portfolio Table 82. Guerbet Group Recent Development Table 83. GE Healthcare Company Information Table 84. GE Healthcare Business Overview Table 85. GE Healthcare Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 86. GE Healthcare Gadoterate Meglumine Product Portfolio Table 87. GE Healthcare Recent Development Table 88. North America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 89. North America Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 90. North America Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 91. North America Gadoterate Meglumine Sales Forecast by Country (2027-2032) & (K L) Table 92. North America Gadoterate Meglumine Sales Market Share Forecast by Country (2027-2032) Table 93. North America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Gadoterate Meglumine Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Gadoterate Meglumine Market Share by Country (2021-2026) Table 96. North America Gadoterate Meglumine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Gadoterate Meglumine Market Share Forecast by Country (2027-2032) Table 98. Europe Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 99. Europe Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 100. Europe Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 101. Europe Gadoterate Meglumine Sales Forecast by Country (2027-2032) & (K L) Table 102. Europe Gadoterate Meglumine Sales Market Share Forecast by Country (2027-2032) Table 103. Europe Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Gadoterate Meglumine Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Gadoterate Meglumine Market Share by Country (2021-2026) Table 106. Europe Gadoterate Meglumine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Gadoterate Meglumine Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 110. Asia-Pacific Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 111. Asia-Pacific Gadoterate Meglumine Sales Forecast by Country (2027-2032) & (K L) Table 112. Asia-Pacific Gadoterate Meglumine Sales Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Gadoterate Meglumine Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Gadoterate Meglumine Market Share by Country (2021-2026) Table 116. Asia-Pacific Gadoterate Meglumine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Gadoterate Meglumine Market Share Forecast by Country (2027-2032) Table 118. Latin America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 119. Latin America Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 120. Latin America Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 121. Latin America Gadoterate Meglumine Sales Forecast by Country (2027-2032) & (K L) Table 122. Latin America Gadoterate Meglumine Sales Market Share Forecast by Country (2027-2032) Table 123. Latin America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Gadoterate Meglumine Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Gadoterate Meglumine Market Share by Country (2021-2026) Table 126. Latin America Gadoterate Meglumine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Gadoterate Meglumine Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 130. Middle East and Africa Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 131. Middle East and Africa Gadoterate Meglumine Sales Forecast by Country (2027-2032) & (K L) Table 132. Middle East and Africa Gadoterate Meglumine Sales Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Gadoterate Meglumine Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East and Africa Gadoterate Meglumine Market Share by Country (2021-2026) Table 136. Middle East and Africa Gadoterate Meglumine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Gadoterate Meglumine Market Share Forecast by Country (2027-2032) Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Gadoterate Meglumine Distributors List Table 141. Gadoterate Meglumine Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Gadoterate Meglumine Image Figure 2. Global Gadoterate Meglumine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadoterate Meglumine Market Size (2021-2032) & (US$ Million) Figure 4. Global Gadoterate Meglumine Sales (2021-2032) & (K L) Figure 5. 5.6535Gm/15Ml Image Figure 6. Global 5.6535Gm/15Ml Sales YoY Growth (2021-2032) & (K L) Figure 7. 3.769Gm/10Ml Image Figure 8. Global 3.769Gm/10Ml Sales YoY Growth (2021-2032) & (K L) Figure 9. 1.8845Gm/5Ml Image Figure 10. Global 1.8845Gm/5Ml Sales YoY Growth (2021-2032) & (K L) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K L) Figure 13. Global Gadoterate Meglumine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Gadoterate Meglumine Market Share by Type 2025 VS 2032 Figure 15. North America Gadoterate Meglumine Sales Market Share in Volume by Type in 2025 Figure 16. North America Gadoterate Meglumine Sales Market Share in Value by Type in 2025 Figure 17. Europe Gadoterate Meglumine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Gadoterate Meglumine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Gadoterate Meglumine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Gadoterate Meglumine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Gadoterate Meglumine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Gadoterate Meglumine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Gadoterate Meglumine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Gadoterate Meglumine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Gadoterate Meglumine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K L) Figure 29. Clinics Image Figure 30. Global Clinics Sales YoY Growth (2021-2032) & (K L) Figure 31. Global Gadoterate Meglumine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gadoterate Meglumine Market Share by Application 2025 VS 2032 Figure 33. North America Gadoterate Meglumine Sales Market Share in Volume by Application in 2025 Figure 34. North America Gadoterate Meglumine Sales Market Share in Value by Application in 2025 Figure 35. Europe Gadoterate Meglumine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Gadoterate Meglumine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Gadoterate Meglumine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Gadoterate Meglumine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Gadoterate Meglumine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Gadoterate Meglumine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Gadoterate Meglumine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Gadoterate Meglumine Sales Market Share in Value by Application in 2025 Figure 43. North America Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 44. North America Gadoterate Meglumine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Gadoterate Meglumine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Gadoterate Meglumine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 48. Europe Gadoterate Meglumine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gadoterate Meglumine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Gadoterate Meglumine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 52. Asia-Pacific Gadoterate Meglumine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gadoterate Meglumine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Gadoterate Meglumine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 56. Latin America Gadoterate Meglumine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gadoterate Meglumine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Gadoterate Meglumine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 60. Middle East and Africa Gadoterate Meglumine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gadoterate Meglumine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Gadoterate Meglumine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Gadoterate Meglumine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Gadoterate Meglumine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5.6535Gm/15Ml
  • 3.769Gm/10Ml
  • 1.8845Gm/5Ml
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hengrui Medicine
  • Guerbet Group
  • GE Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadoterate Meglumine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gadoterate Meglumine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gadoterate Meglumine Market by Type
  6. 1.3.1 5.6535Gm/15Ml
  7. 1.3.2 3.769Gm/10Ml
  8. 1.3.3 1.8845Gm/5Ml
  9. 1.3.4 Others
  10. 1.4 Global Gadoterate Meglumine Market Size by Type
  11. 1.4.1 Global Gadoterate Meglumine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Gadoterate Meglumine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Gadoterate Meglumine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Gadoterate Meglumine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Gadoterate Meglumine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Gadoterate Meglumine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Gadoterate Meglumine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Gadoterate Meglumine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gadoterate Meglumine Industry Trends
  2. 2.2 Gadoterate Meglumine Industry Drivers
  3. 2.3 Gadoterate Meglumine Industry Opportunities and Challenges
  4. 2.4 Gadoterate Meglumine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gadoterate Meglumine Revenue (2021-2026)
  2. 3.2 Global Top Players by Gadoterate Meglumine Sales (2021-2026)
  3. 3.3 Global Top Players by Gadoterate Meglumine Price (2021-2026)
  4. 3.4 Global Gadoterate Meglumine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gadoterate Meglumine Major Company Production Sites & Headquarters
  6. 3.6 Global Gadoterate Meglumine Company, Product Type & Application
  7. 3.7 Global Gadoterate Meglumine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gadoterate Meglumine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gadoterate Meglumine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gadoterate Meglumine Tier 1, Tier 2, and Tier 3
4 Gadoterate Meglumine Regional Status and Outlook
  1. 4.1 Global Gadoterate Meglumine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gadoterate Meglumine Historic Market Size by Region
  3. 4.2.1 Global Gadoterate Meglumine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gadoterate Meglumine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gadoterate Meglumine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gadoterate Meglumine Forecasted Market Size by Region
  7. 4.3.1 Global Gadoterate Meglumine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gadoterate Meglumine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gadoterate Meglumine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gadoterate Meglumine by Application
  1. 5.1 Gadoterate Meglumine Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Gadoterate Meglumine Market Size by Application
  5. 5.2.1 Global Gadoterate Meglumine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Gadoterate Meglumine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Gadoterate Meglumine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Gadoterate Meglumine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Gadoterate Meglumine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Gadoterate Meglumine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Gadoterate Meglumine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Gadoterate Meglumine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hengrui Medicine
  2. 6.1.1 Hengrui Medicine Company Information
  3. 6.1.2 Hengrui Medicine Business Overview
  4. 6.1.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
  6. 6.1.5 Hengrui Medicine Recent Developments
  7. 6.2 Guerbet Group
  8. 6.2.1 Guerbet Group Company Information
  9. 6.2.2 Guerbet Group Business Overview
  10. 6.2.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guerbet Group Gadoterate Meglumine Product Portfolio
  12. 6.2.5 Guerbet Group Recent Developments
  13. 6.3 GE Healthcare
  14. 6.3.1 GE Healthcare Company Information
  15. 6.3.2 GE Healthcare Business Overview
  16. 6.3.3 GE Healthcare Gadoterate Meglumine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GE Healthcare Gadoterate Meglumine Product Portfolio
  18. 6.3.5 GE Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Gadoterate Meglumine Sales by Country
  2. 7.1.1 North America Gadoterate Meglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gadoterate Meglumine Sales by Country (2021-2026)
  4. 7.1.3 North America Gadoterate Meglumine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gadoterate Meglumine Market Size by Country
  6. 7.2.1 North America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gadoterate Meglumine Market Size by Country (2021-2026)
  8. 7.2.3 North America Gadoterate Meglumine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gadoterate Meglumine Sales by Country
  2. 8.1.1 Europe Gadoterate Meglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gadoterate Meglumine Sales by Country (2021-2026)
  4. 8.1.3 Europe Gadoterate Meglumine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gadoterate Meglumine Market Size by Country
  6. 8.2.1 Europe Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gadoterate Meglumine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gadoterate Meglumine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gadoterate Meglumine Sales by Country
  2. 9.1.1 Asia-Pacific Gadoterate Meglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gadoterate Meglumine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gadoterate Meglumine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gadoterate Meglumine Market Size by Country
  6. 9.2.1 Asia-Pacific Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gadoterate Meglumine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gadoterate Meglumine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gadoterate Meglumine Sales by Country
  2. 10.1.1 South America Gadoterate Meglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gadoterate Meglumine Sales by Country (2021-2026)
  4. 10.1.3 South America Gadoterate Meglumine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gadoterate Meglumine Market Size by Country
  6. 10.2.1 South America Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gadoterate Meglumine Market Size by Country (2021-2026)
  8. 10.2.3 South America Gadoterate Meglumine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gadoterate Meglumine Sales by Country
  2. 11.1.1 Middle East and Africa Gadoterate Meglumine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gadoterate Meglumine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gadoterate Meglumine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gadoterate Meglumine Market Size by Country
  6. 11.2.1 Middle East and Africa Gadoterate Meglumine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gadoterate Meglumine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gadoterate Meglumine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gadoterate Meglumine Value Chain Analysis
  2. 12.1.1 Gadoterate Meglumine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gadoterate Meglumine Production Mode & Process
  7. 12.2 Gadoterate Meglumine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gadoterate Meglumine Distributors
  10. 12.2.3 Gadoterate Meglumine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst